Myogrel plus

Indication :

Myogrel plus is indicated for the prevention of atherothrombotic events
in adult patients already taking both clopidogrel and acetylsalicylic acid (ASA).
Myogrel plus is a fixed-dose combination medicinal product for continuation of therapy in:
-Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial
infarction) including patients undergoing a stent placement following percutaneous coronary
intervention
-ST segment elevation acute myocardial infarction in medically treated patients eligible for
thrombolytic therapy

Composition :

Each film-coated tablet contains: 75 mg of clopidogrel (as Bisulphate) and 75 mg of acetylsalicylic
acid (ASA).